PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $135,000 | -36.9% | 35,630 | -15.1% | 0.00% | -20.0% |
Q4 2019 | $214,000 | -96.6% | 41,980 | -96.7% | 0.01% | -96.7% |
Q3 2019 | $6,355,000 | -20.7% | 1,257,098 | -3.2% | 0.15% | -20.2% |
Q2 2019 | $8,013,000 | +21.8% | 1,298,723 | -8.4% | 0.19% | +26.2% |
Q1 2019 | $6,581,000 | +8.5% | 1,418,391 | -1.8% | 0.15% | -5.1% |
Q4 2018 | $6,068,000 | -36.8% | 1,444,866 | -5.6% | 0.16% | -21.1% |
Q3 2018 | $9,597,000 | -33.3% | 1,530,657 | -14.4% | 0.20% | -32.8% |
Q2 2018 | $14,384,000 | -8.3% | 1,789,073 | -14.9% | 0.30% | -3.6% |
Q1 2018 | $15,678,000 | +19.1% | 2,101,668 | -5.0% | 0.31% | +21.3% |
Q4 2017 | $13,168,000 | -25.0% | 2,213,118 | -7.2% | 0.25% | -21.9% |
Q3 2017 | $17,552,000 | +5.3% | 2,384,833 | -2.9% | 0.32% | +1.2% |
Q2 2017 | $16,669,000 | -30.8% | 2,454,918 | -3.9% | 0.32% | -30.4% |
Q1 2017 | $24,104,000 | +4.7% | 2,553,438 | -4.2% | 0.46% | -1.1% |
Q4 2016 | $23,025,000 | +29.2% | 2,664,940 | -5.3% | 0.46% | +30.3% |
Q3 2016 | $17,816,000 | +48.4% | 2,814,540 | -1.1% | 0.36% | +37.8% |
Q2 2016 | $12,006,000 | – | 2,844,920 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |